Cost-of-illness study of patients with allergic asthma and seasonal allergic rhinitis in Germany Source: Eur Respir J 2001; 18: Suppl. 33, 399s Year: 2001
Visible moulds, non-allergic and allergic rhinitis and asthma in adults: the EGEA study Source: Virtual Congress 2021 – Occupational rhinitis and asthma Year: 2021
Long-term trends of asthma, allergic rhinitis and atopic eczema in young Finnish men: a retrospective analysis, 1926–2017 Source: Eur Respir J, 56 (6) 1902144; 10.1183/13993003.02144-2019 Year: 2020
Allergy markers in relation to allergic rhinitis and asthma in relatives of asthmatics in the EGEA study Source: Eur Respir J 2003; 22: Suppl. 45, 115s Year: 2003
Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Omalizumab in allergic and non-allergic patients: results of FENOMA study Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Allergic rhinitis and coexistence of allergic rhinitis and asthma at Greek children. Comparison of clinical and laboratory pararameters Source: Eur Respir J 2006; 28: Suppl. 50, 255s Year: 2006
Traffic exposure associated with allergic asthma and allergic rhinitis in adults. A cross-sectional study in southern Sweden Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009
Allergic rhinitis in children with asthma: a cross-sectional questionnaire-based survey Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Impact of subcutaneous allergoid AIT on patients with allergic rhinitis and/or asthma: A retrospective real-life, long-term cohort analysis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020
Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Prognosis of allergic and non-allergic asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Is DawNO a new measurement to characterise allergic and non-allergic asthma? Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009
Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021